Spirit Health has been awarded a European Space Agency (ESA) Business Applications and Space Solutions contract and funding to deliver real-time remote monitoring for patients with long-term conditions augmented with accurate, location-based satellite air quality data to enhance care provision and patient self-management options.
Clinitouch will provide patients and clinicians with real-time visibility through an enhanced system that provides advanced warning of when a patient’s condition is likely to deteriorate by vital signs monitoring – enabling prompt pre-emptive interventions for the patient and the healthcare practitioner. Providing air quality data will give patients real-time information empowering them to help make decisions about how they manage their day.
Clinitouch is a proven and CE marked medical device that proactively improves patient outcomes by reducing hospital admissions, enhancing case management capacity, preventing acute exacerbations, improving efficiency and collaboration and promoting patient self-management. In its Leicester COPD service, the digital platform has delivered a 67% reduction in emergency admissions amongst high-risk patients, working in parallel with health coaching and specialist nurse interventions.
With this new ESA initiative, Spirit Health will lead a project team comprising air quality expert, EarthSense; not-for-profit innovation and technology network, Satellite Applications Catapult; and NHS support organisation Arden & GEM Commissioning Support Unit, to add Earth Observation data into Clinitouch for improved healthcare decisions.This data includes:
In addition, GNSS data is used for location tracking for both patients and mobile air quality sensors and provides tailored position-based information on pollution concentrations.
Clinitouch is being developed to help people with respiratory conditions, initially COPD, better plan their day so that they can have better health outcomes. Plans to expand the platform to include asthma and other respiratory conditions are in place.
Chris Barker, CEO, Spirit Health Group, comments: “In the UK alone, 1.2 million people are diagnosed with COPD, with in excess of 140,000 unscheduled hospital admissions and 30,000 deaths per year. We know that poor air quality contributes to morbidity and mortality, and is estimated to have cost £157 million in health and social care in 2017. Yet, we can change this!
“By providing an enhanced system that will offer advanced warning of potential condition deterioration alongside pre-emptive intervention data, we can shift the focus from treatment to prevention.
"We are delighted that the ESA has recognised the huge potential of Clinitouch and are thrilled to be working alongside our partners to deliver this ground-breaking project.”
Spirit Health has been awarded a European Space Agency (ESA) Business Applications and Space Solutions contract and funding to deliver real-time remote monitoring for patients with long-term conditions augmented with accurate, location-based satellite air quality data to enhance care provision and patient self-management options.
Clinitouch will provide patients and clinicians with real-time visibility through an enhanced system that provides advanced warning of when a patient’s condition is likely to deteriorate by vital signs monitoring – enabling prompt pre-emptive interventions for the patient and the healthcare practitioner. Providing air quality data will give patients real-time information empowering them to help make decisions about how they manage their day.
Clinitouch is a proven and CE marked medical device that proactively improves patient outcomes by reducing hospital admissions, enhancing case management capacity, preventing acute exacerbations, improving efficiency and collaboration and promoting patient self-management. In its Leicester COPD service, the digital platform has delivered a 67% reduction in emergency admissions amongst high-risk patients, working in parallel with health coaching and specialist nurse interventions.
With this new ESA initiative, Spirit Health will lead a project team comprising air quality expert, EarthSense; not-for-profit innovation and technology network, Satellite Applications Catapult; and NHS support organisation Arden & GEM Commissioning Support Unit, to add Earth Observation data into Clinitouch for improved healthcare decisions.This data includes:
In addition, GNSS data is used for location tracking for both patients and mobile air quality sensors and provides tailored position-based information on pollution concentrations.
Clinitouch is being developed to help people with respiratory conditions, initially COPD, better plan their day so that they can have better health outcomes. Plans to expand the platform to include asthma and other respiratory conditions are in place.
Chris Barker, CEO, Spirit Health Group, comments: “In the UK alone, 1.2 million people are diagnosed with COPD, with in excess of 140,000 unscheduled hospital admissions and 30,000 deaths per year. We know that poor air quality contributes to morbidity and mortality, and is estimated to have cost £157 million in health and social care in 2017. Yet, we can change this!
“By providing an enhanced system that will offer advanced warning of potential condition deterioration alongside pre-emptive intervention data, we can shift the focus from treatment to prevention.
"We are delighted that the ESA has recognised the huge potential of Clinitouch and are thrilled to be working alongside our partners to deliver this ground-breaking project.”
Shaping the future of healthcare by making it easy and accessible for everyone, no matter their location.
